Meta AnalysisID 7900
补硒对非甲状腺疾病综合征危重患者甲状腺激素的影响：系统评价与Meta分析
CRD42023487978
What is the selenium Supplementation Effect On Thyroid Hormone In Critically Ill Patients With Non-thyroidal Illness?
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 7900
- Evidence Id
- 16458
- Core Evidence Id
- 16458
- Source Meta Analysis Id
- 7896
- Herb2 Meta Analysis Id
- HBMA007896
- Crd Id
- CRD42023487978
- Title
- Selenium Supplementation Effect On Thyroid Hormone In Critically Ill Patients With Non-thyroidal Illness: Systematic Review And Meta-Analysis
- Review Question
- What is the selenium Supplementation Effect On Thyroid Hormone In Critically Ill Patients With Non-thyroidal Illness?
- Study Type Included
- This study consisted of randomized controlled trials (RCTs) comparing patients who had a non-thyroidal illness, no history of thyroid illness, and were either given a placebo or selenium supplementation. The following were the exclusion criteria: (1) Studies in animals, (2) Studies in languages other than English, (3) duplicates (4) Studies that are abstract only and without fulltext.
- Condition Being Studied
- Non-thyroidal Illness (NTI) is a syndrome that occurs when serum thyroid hormone levels drop during starvation and illness. This only involves a decrease in serum triiodothyronine (T3) in mild illness. However, as the severity and length of the illness increase, there is also a decrease in both serum T3 and thyroxine (T4)
- Participant
- This study consisted of randomized controlled trials (RCTs) comparing patients who had a non-thyroidal illness, no history of thyroid illness, and were either given a placebo or selenium supplementation
- Animal
- Human Disease Modelled
- Intervention
- Selenium The following were the exclusion criteria: (1) Studies in animals, (2) Studies in languages other than English, (3) duplicates (4) Studies that are abstract only and without fulltext.
- Comparator Control
- placebo
- Main Outcome
- The study consisted of randomized controlled trials (RCTs) comparing patients who had a non-thyroidal illness, no history of thyroid illness, and were either given a placebo or selenium supplementation and measured one or more outcomes included but not limited to mortality triiodothyronine (T3), freeT3 (fT3), thyroxine (T4), freeT4 (fT4), thyroid-stimulating hormone (TSH), and reverse T3 (rT3) Measures of effect Relative risk and mean difference or standardized mean difference
- Outcome Measure
- Additional Outcome
- Study Method
- Intervention, Systematic review
- Keyword
- MeSH headings have not been applied to this record
- Contact
- Christian Julio Suhardi [email protected]
- Organisational Affiliation
- Universitas Airlangga
- Funding Source
- no Grant number(s) State the funder, grant or award number and the date of award no
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- Indonesia
- Review Stage
- Review Ongoing
- First Submission Date
- 2023-11-29
- Registration Date
- 2023-12-12
- Anticipated Start Date
- 2023-11-30
- Anticipated Completion Date
- 2024-01-15
- Title Cn
- 补硒对非甲状腺疾病综合征危重患者甲状腺激素的影响：系统评价与Meta分析
- Title En
- Selenium Supplementation Effect On Thyroid Hormone In Critically Ill Patients With Non-thyroidal Illness: Systematic Review And Meta-Analysis
- Bilingual Status
- complete